Cancom SE (0O0F)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 22.05 |
|---|---|
| 52-week range | 20.10 – 29.45 |
| Return, 1 month / 3 months | −1.3% / −3.9% |
| Return, 1 year / 3 years | −8.6% / +1.2% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -27.8% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cancom SE is a German information technology services company based in Munich. It supplies business customers with IT infrastructure, cloud services and managed services, and it also resells hardware and software from other vendors. Its clients are mainly organisations in the private and public sectors that rely on Cancom to plan, build and run their computing environments, including networking, data centre and workplace systems, along with support and consulting around those technologies.
The shares are listed on the London Exchange in UK under the code 0O0F, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cancom SE (0O0F) trades on the London Exchange in UK. It last closed at EUR 22.05 on 23 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 2,570 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.6% and over the last three months it fell 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.1% | ||
| From 52-week high | -24.0% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.9% | ||
| 6-month return | -7.9% | ||
| 12-month return, skipping the last month | -7.3% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.8% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 16.7% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −1.3% |
| 3 months | −3.9% |
| 6 months | −7.9% |
| 1 year | −8.6% |
| 3 years | +1.2% |
| 5 years | −53.9% |
Signals
| 50-day / 200-day average | 22.29 / 23.72 |
|---|---|
| Golden / death cross (60 days) | Death, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | EUR 1.0000 |
| 25 Jun 2025 | EUR 1.0000 |
| 6 Jun 2024 | EUR 1.0000 |
| 15 Jun 2023 | EUR 1.0000 |
| 29 Jun 2022 | EUR 1.0000 |
| 30 Jun 2021 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.